Preliminary study on recombinant human soluble thrombomodulin (rTM) administration for treatment of pneumonia-induced acute respiratory distress syndrome (ARDS) complicated with disseminated intravascular coagulation(DIC) and sepsis, including avian influenza virus infectio
Not Applicable
- Conditions
- Pneumonia-induced acute respiratory distress syndrome (ARDS) complicated with disseminated intravascular coagulation(DIC) and sepsis, including avian influenza virus infection
- Registration Number
- JPRN-UMIN000020358
- Lead Sponsor
- ational Hospital for Pediatrics, Nanoi, Vietnam
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who fulfill any of the followings are excluded 1. Patients with severe renal dysfunction (creatinine clearance < 10mL/min) 2. Patients with bleeding symptoms. 3. Patients whom the treating doctor deems, for any reason, to be ineligible.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method